TIEFENBACHER PHARMACEUTICALS: Product Portfolio
Generic, value added, and innovative products including highly potent drugs for patients worldwide
Tiefenbacher Pharmaceuticals: Everything from a single source. Gain access to novel products (FDF + highly potent drugs), speed up time-to-market and open up unexplored business avenues. We are developing high-quality pharmaceuticals with a patients-centered approach adapted for each market worldwide.
We have successfully developed and marketed a range of products, many of which are leaders in their respective markets. We provide over 180+ products across various therapeutic categories in 10+ dosage forms including highly potent drugs – and additional drug medical device combinations. We are not limited to specific disease areas: whether for widespread or for orphan diseases. Please have a look at our portfolio of products that we have available for out-licensing.
- We are ready to offer sustainable packaging: HDPE bottles and sustainable blisters
| Product | Brand (RLD) | Therapeutical Group | ATC-Indication | Pharmaceutical Form | Strength | Under Development | Under Registration | Available |
|---|---|---|---|---|---|---|---|---|
| Alectinib (IN-HOUSE) | Alecensa® | Antineoplastic and Immunomodulating Agents | L01E Protein Kinase Inhibitors | Capsule | 150mg* *(Zone IVb) | Under Development | ||
| Alitretinoin (IN-HOUSE) | Toctino® | Dermatologicals | D11A other dermatological agents for dermatitis excl. Corticosteroids | Capsule | 10mg 30mg | Under Development | ||
| Apraclonidine | Iodipine® | Sensory Organs | S01E Antiglaucoma preparations and miotics | Solution | 10 mg/ml (1%) | Under Development | ||
| Bempedoic Acid | Nilemdo® | Cardiovascular System | C10AX15 Hypercholesterolemia | Tablet | 180 mg | Under Development | ||
| Bempedoic Acid/ Ezetimib | Nustendi® | Cardiovascular System | C10BA10 Hypercholesterolemia | Tablet | 180 mg/10mg | Under Development | ||
| Bilastine | Bilaxten® | Respiratory System | R06A Antihistamines for systemic use | Oral Solution | 10mg/4ml* *(Zone IVb) | Under Development | ||
| Brigatinib | Alunbrig® | Antineoplastic and Immunomodulating Agents | L01E adults with non-small cell lung cancer (NSCLC) w ALK rearragement | Tablet | 30mg 90mg 180mg | Under Development | ||
| Cenobamante | Ontozry® | Nervous System | N03A Antiepileptic | Tablet | 12,5 mg 25 mg 50 mg 100 mg 150 mg 200 mg | Under Development | ||
| Dihydralazine (IN-HOUSE) | Nepresol® | Cardiovascular System | C02C Antiadrenergic agents, peripherally active | Tablet | 25 mg 50 mg *(Zone IVb) | Under Development | ||
| Enzalutamide | Xtandi® | Antineoplastic and Immunomodulating Agents | L02B Hormone antagonists and related agents (Prostatic Neoplasms) | Tablet | 40mg 80mg 120mg 160mg | Under Development | ||
| Fidaxomicin (IN-HOUSE) | Dificlir® | Alimentary Tract and Metabolism | A07A Intestinal Antiinfectives | Film-coated tablet | 200mg | Under Development | ||
| Fostamatinib (IN-HOUSE) | Tavlesse® | Hematology | B02B Vitamin K and other hemostatics | Film-coated tablet | 100mg 150mg | Under Development | ||
| Gilteritinib | Xospata® | Antineoplastic and Immunomodulating Agents | L01E Leukaemia | Film-coated tablet | 40mg | Under Development | ||
| Lithium XR (IN-HOUSE) | Quilonum® | Nervous System | N05AN Psycholeptics bipolar disorders major depression cluster headache | Extended Release tablet | 300mg* 450mg* 625mg* *(Zone IVb) | Under Development | ||
| Mexiletine | NaMuscla® | Central Nervous System (CNS) | M09A – Other drugs for disorders of the Musculoskeletal system | hard capsules | 167 mg | Under Development | ||
| Neratinib (IN-HOUSE) | Nerlynx® | Antineoplastic drugs | L01E Antineo-plastic drugs (early-stage hormone receptor positive HER2- overexpressed/amplified breast cancer) | Film-coated tablet | 40mg* 120mg* *(Zone IVb) | Under Development | ||
| Netupitant+ Palonosetron (IN-HOUSE) | Akynzeo® | Antineoplastic and Immunomodulating Agents | A04AA Serotonin antagonists | Tablet | 300mg+0.5mg* *(Zone IVb) | Under Development | ||
| Opicapone (IN-HOUSE) | Ongentys® | Nervous System | N04B Dopaminergic Agents | Capsule | 25mg 50mg | Under Development | ||
| Osilodrostat (IN-HOUSE) | Isturisa® | Endocrinology | H02C Antiadrenal preparations (Cushing’s syndrome) | Film-coated tablet | 1mg 2mg 5mg 10mg | Under Development | ||
| Ponatinib | Iclusig® | Antineoplastic and Immunomodulating Agents | L01E chronic myelogenous leukaemia (CML) | Tablet | 15mg 30mg 45mg | Under Development | ||
| Propranolol | Hemangiol® | Dermatological | C07A Proliferating infantile hemangioma | Oral Solution | 3,75 mg/ml | Under Development | ||
| Regorafenib (IN-HOUSE) | Stivarga® | Antineoplastic and Immunomodulating Agents | L01E Protein kinase inhibitor colorectal cancer gastrointestinal stromal tumors hepatocellular carcinoma | Tablet | 40mg* 160mg* *(Zone IVb) | Under Development | ||
| Ripretinib (IN-HOUSE) | Qinlock® | Antineoplastic and Immunomodulating Agents | L01E Protein kinase inhibitor | Tablet | 50mg* *(Zone Ivb | Under Development | ||
| Trientine (IN-HOUSE) | Cuprior™ | Alimentary Tract and Metabolism | A16A Other Alimentary Tract And Metabolism Products | Film-coated tablet | 75mg* 150mg* *(Zone IVb) | Under Development | ||
| Venetoclax (IN-HOUSE) | Venclexta®/ Venclyxto® | Antineoplastic and Immunomodulating Agents | L01X Other antineoplastic agents (Chronic lymphocytic leukaemia (CLL), acute myeloid leukaemia (AML)) | Film-coated tablet | 10mg 50mg 100mg* *(Zone IVb) | Under Development | ||
| Vismodegib (IN-HOUSE) | Erivedge® | Antineoplastic and Immunomodulating Agents | L01XJ01 Hedgehog pathway inhibitors | Capsule | 150mg* *(Zone IVb) | Under Development | ||
| Butylscopolamin+ Paracetamol (IN-HOUSE) | Buscopan PLUS® | Alimentary Tract and Metabolism | A03B Belladonna and derivatives, plain (Spasmolytic) | Film-coated tablet | 10mg+500mg* | Under Registration | 1 | |
| Ibuprofen+ Caffeine | Thomapyrin Tension Duo® | Musculo-Skeletal System | M01A Antiinflammatory And Antirheumatic Products, Non-Steroids | Sachet | 400mg+100mg* *(Zone IVb) | Under Registration | 1 | |
| Levamlodipine (except US) | Conjupri® | Cardiovascular System | C08C Selective calcium channel blockers with mainly vascular effects | Tablet | 2,5mg 5mg | Under Registration | 1 | |
| Minoxidil | Lonolox® | Cardiovascular System | C02DC01 Therapy resistant hypertension | Tablet | 2,5 mg 5 mg 10 mg | Under Registration | 1 | |
| Mercaptamine (IN-HOUSE) | Procysbi ® | Alimentary Tract and Metabolism | A16A Other alimentary tract and metabolism products (Cystinosis) | Capsule and stick pack | 25mg* cap. 75mg* cap. 75mg* stick packs 300mg* stick packs | Under Registration | 1 | |
| Olaparib | Lynparza® | Antineoplastic and Immunomodulating Agents | L01X Cancer Ovarian, Breast, Prostate, Pancreas | Film-coated tablet | 100mg* 150mg* *(Zone IVb) | Under Registration | 1 | |
| Pitolisant (IN-HOUSE) | Wakix® Ozawade® | Nervous system | N07X treatment of narcolepsy with or without cataplexy | Tablet | 4,5mg* 18mg* *(Zone IVb) | Under Registration | 1 | |
| Posaconazol (IN-HOUSE) | Noxafil® | Antiinfectives For Systemic Use | J02A Antimycotics for systemic use (Antifungal) | Gastro-resistant tablet | 300mg* *(Zone IVb) | Under Registration | 1 | |
| Pridinol | Lyseen® | Musculo-Skeletal System | M03B Muscle spasms, Lumbar pain, Torticollis, General muscle pain | Tablet | 1,5mg 3mg *(Zone IVb) | Under Registration | 1 | |
| Safinamide (IN-HOUSE) | Xadago® | Nervous system | N04B Parkinson disease | Film-coated tablet | 50mg* 100mg* *(Zone IVb) | Under Registration | 1 | |
| Abiraterone | Zytiga® | Antineoplastic and Immunomodulating Agents | L02B Hormone antagonists and related agents (Prostatic Neoplasms) | Tablet, Film-coated tablet | 250mg* 500mg* *(Zone IVb) | Available | ||
| Abiraterone + Prednisolone | Abiraterone:Zytiga® Prednisolone:Pfizer® | Antineoplastic and Immunomodulating Agents | L02B Hormone antagonists and related agents (Prostatic Neoplasms) | Film-coated tablet | 500mg+5mg 500mg+10mg | Available | ||
| Ambrisentan (IN-HOUSE) | Volibris® | Cardiovascular System | C02K Other antihypertensives (Pulmonary, Arterial Hypertension) | Film-coated tablet | 5mg* 10mg* *(Zone IVb) | Available | ||
| Amifampridine (IN-HOUSE) | Firdapse® | Nervous System | N07X Other nervous system drugs (Lambert-Eaton Myasthenic Syndrome) | Tablet | 10mg | Available | ||
| Apixaban | Eliquis® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke, Heart Attack) | Tablet | 2.5mg, 5mg | Available | ||
| Apremilast (IN-HOUSE) | Otezla® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Psoriasis and psoriatic arthritis) | Film-coated tablet | 10mg 20mg 30mg | Available | ||
| Arsenic trioxide | Trisenox® | Antineoplastic and Immunomodulating Agents | L01XX27 Induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) | vial | 1 mg/ml | Available | ||
| Atorvastatin+ Ezetimibe | Atozet® | Cardiovascular System | C10B Lipid modifying agents, combinations (Hyperlipidemia) | Film-coated tablet | 10mg+10mg 20mg+10mg 40mg+10mg 80mg+10mg | Available | ||
| Bilastine | Bilaxten® | Respiratory System | R06A Antihistamines for systemic use | Tablet | 20mg* *(Zone IVb) | Available | ||
| Bilastine ODT | Bilaxten® | Respiratory System | R06A Antihistamines for systemic use | Orodispersible tablet | 10mg 20mg* *(Zone IVb) | Available | ||
| Bimatoprost | Lumigan® | Sensory Organs | S01E Antiglaucoma | Solution | 0.1mg/ml 0.3mg/ml | Available | ||
| Bimatoprost+ Timolol | Ganfort® | Sensory Organs | S01E Antiglaucoma | Solution | 0.3mg/ml+5mg/ml | Available | ||
| Brimonidine | Alphagan® | Sensory Organs | S01G Decongestants and antiallergics | Solution | 2mg/ml | Available | ||
| Brimonidine+ Timolol | Combigan® | Sensory Organs | S01G Decongestants and antiallergics | Solution | 2mg+5mg/ml* | Available | ||
| Brivudine (IN-HOUSE) | Zostex® | Anti-infective for Systemic Use | J05A Antiviral (Herpes Zoster) | Tablet | 125mg* *(Zone IVb) | Available | ||
| Buprenorphine | Transtec PRO® | Nervous System | N02A Opioids (Analgesic Malignant Pain) | Transdermal patch | 35μg/h* 52.5μg/h 70μg/h* (4‐day patch) *(Zone IVb) | Available | ||
| Buprenorphine | Norspan® | Nervous System | N02A Opioids (Analgesic Non‐Malignant Pain) | Transdermal patch | 5μg/h 10μg/h 15μg/h 20μg/h (7‐day patch) | Available | ||
| Carvedilol (IN-HOUSE) | Dilatrend® | Cardiovascular System | C07A Beta blocking agents (Hypertension) | Film-coated tablet | 3.125mg 6.25mg 12.5mg 25mg | Available | ||
| Edoxaban (IN-HOUSE) | Lixiana® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke) | Film-coated tablet | 15mg* 30mg* 60mg* *(Zone IVb) | Available | ||
| Escitalopram (IN-HOUSE) | Cipralex® | Nervous System | N06A Antidepressants (Depression) | Film-coated tablet | 5mg 10mg 15mg 20mg* *(Zone IVb) | Available | ||
| Eslicarbazepin (IN-HOUSE) | Exalief®/ Zebinix® | Nervous System | N03A Antiepileptics (Epilepsy) | Tablet | 200mg* 400mg* 600mg* 800mg* *(Zone IVb) | Available | ||
| Eszopiclone | Lunesta®/ Eszop® | Nervous System | N05C Hypnotics and sedatives (Insomnia) | Film-coated tablet | 1mg 2mg 3mg | Available | ||
| Etoricoxib (IN-HOUSE) | Arcoxia® | Musculo-Skeletal System | M01A Antirheumatic | Film-coated tablet | 30mg* 60mg* 90mg* 120mg* *(Zone IVb) | Available | ||
| Gabapentin | Neurontin® | Nervous System | N03A Antiepileptics (Epilepsy) | Capsule | 100mg 300mg 400mg | Available | ||
| Gabapentin | Neurontin® | Nervous System | N03A Antiepileptics (Epilepsy) | Film-coated tablet | 600mg 800mg | Available | ||
| Ivabradine (IN-HOUSE) | Procoralan® | Cardiovascular System | C01E Other cardiac preparations (Angina pectoris) | Film-coated tablet | 5mg* 7.5mg* *(Zone IVb) | Available | ||
| Lacosamide | Vimpat® | Nervous System | N03A Antiepileptics (Epilepsy) | Film-coated tablet | 50mg* 100mg* 150mg* 200mg* *(Zone IVb) | Available | ||
| Lamotrigine | Lamictal® | Nervous System | N03A Antiepileptics (Epilepsy, Depression) | Tablet | 25mg 50mg 100mg 200mg | Available | ||
| Latanoprost | Xalatan® | Sensory Organs | S01E Antiglaucoma | Solution | 50μg/ml | Available | ||
| Latanoprost+ Timolol | Xalacom® | Sensory Organs | S01E Antiglaucoma | Solution | 50μg/ml+5mg/ml | Available | ||
| Leflunomide | Arava® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Rheumatoid arthritis and psoriatic arthritis) | Film-coated tablet | 10mg 20mg* *(Zone IVb) | Available | ||
| Leflunomide | Arava® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Rheumatoid arthritis and psoriatic arthritis) | Film-coated tablet | 15mg* *(Zone IVb) | Available | ||
| Montelukast | Singulair® | Respiratory System | R03D Other systemic drugs for obstructive airway diseases | Chewable tablet | 4mg 5mg | Available | ||
| Montelukast | Singulair® | Respiratory System | R03D Other systemic drugs for obstructive airway diseases | Film-coated tablet | 10mg* *(Zone IVb) | Available | ||
| Nalmefene | Selincro® | Nervous System | N07B Alcohol-Related Disorders | Film-coated tablet | 18mg* *(Zone IVb) | Available | ||
| Pantoprazole (IN-HOUSE) | Pantozol® | Alimentary Tract and Metabolism | A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (Proton Pump Inhibitor) | Enteric‐coated tablet | 20mg* 40mg* *(Zone IVb) | Available | ||
| Posaconazol (IN-HOUSE) | Noxafil® | Anti-infective for Systemic Use | J02A Antimycotics for systemic use (Antifungal) | Gastro-resistant tablet | 100mg* *(Zone IVb) | Available | ||
| Pravastatin | Pravasin® | Cardiovascular System | C10A Lipid modifying agents, plain (Cholesterol‐Lowering) | Film-coated tablet | 10mg 20mg 40mg | Available | ||
| Prucaloprid (IN-HOUSE) | Resolor® | Alimentary Tract and Metabolism | A06A Drugs for constipation | Film-coated tablet | 1mg* 2mg* *(Zone IVb) | Available | ||
| Quinine Sulfate (IN-HOUSE) | Limptar® | Musculo-skeletal system | P01BC01, M09AA72 Muscle relaxant, antimalarial agent | Film-coated tablet | 200mg | Available | ||
| Rasagiline (IN-HOUSE) | Azilect® | Nervous System | N04B Dopaminergic agents (Parkinson) | Tablet | 1mg* *(Zone IVb) | Available | ||
| Rivaroxaban (IN-HOUSE) | Xarelto® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke, Heart Attack) | Film-coated tablet | 2.5mg 10mg* 15mg* 20mg* *(Zone IVb) | Available | ||
| Sacubitril+ Valsartan EU (IN-HOUSE) | Entresto® | Cardiovascular System | C09D Angiotensin II receptor blockers (ARBs), plain (Chronic Heart Failure) | Film-coated tablet | 24mg+26mg* 49mg+51mg* 97mg+103mg* *(Zone IVb) | Available | ||
| Teriflunomide (IN-HOUSE) | Aubagio® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Multiple Sclerosis) | Film-coated tablet | 7mg 14mg* *(Zone IVb) | Available | ||
| Ticagrelor (IN-HOUSE) | Brilique® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke, Heart Attack) | Film-coated tablet | 60mg* 90mg* *(Zone IVb) | Available | ||
| Varenicline Citrate (IN-HOUSE) | Champix® | Nervous System | N07B Drugs used in addictive disorders (Nicotine Dependents) | Film-coated tablet | 0.5mg* 1mg* *(Zone IVb) | Available | ||
| Vildagliptin | Galvus® | Alimentary Tract and Metabolism | A10B Blood glucose lowering drugs, excluding insulins (Diabetes Mellitus) | Tablet | 50mg* *(Zone IVb) | Available | ||
| Vildagliptin+ Metformin | Eucreas® | Alimentary Tract and Metabolism | A10B Blood glucose lowering drugs, excluding insulins (Diabetes Mellitus) | Film-coated tablet | (50mg+500mg*) 50mg+850mg* 50mg+1000mg* *(Zone IVb) | Available | ||